Literature DB >> 8914737

Novel missense mutation in the cyclic nucleotide-binding domain of HERG causes long QT syndrome.

C A Satler1, E P Walsh, M R Vesely, M H Plummer, G S Ginsburg, H J Jacob.   

Abstract

Autosomal-dominant long QT syndrome (LQT) is an inherited disorder, predisposing affected individuals to sudden death from tachyarrhythmias. To identify the gene(s) responsible for LQT, we identified and characterized an LQT family consisting of 48 individuals. DNA was screened with 150 microsatellite polymorphic markers encompassing approximately 70% of the genome. We found evidence for linkage of the LQT phenotype to chromosome 7(q35-36). Marker D7S636 yielded a maximum lod score of 6.93 at a recombination fraction (theta) of 0.00. Haplotype analysis further localized the LQT gene within a 6.2-cM interval. HERG encodes a potassium channel which has been mapped to this region. Single-strand conformational polymorphism analyses demonstrated aberrant bands that were unique to all affected individuals. DNA sequencing of the aberrant bands demonstrated a G to A substitution in all affected patients; this point mutation results in the substitution of a highly conserved valine residue with a methionine (V822M) in the cyclic nucleotide-binding domain of this potassium channel. The cosegregation of this distinct mutation with LQT demonstrates that HERG is the LQT gene in this pedigree. Furthermore, the location and character of this mutation suggests that the cyclic nucleotide-binding domain of the potassium channel encoded by HERG plays an important role in normal cardiac repolarization and may decrease susceptibility to ventricular tachyarrhythmias.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8914737     DOI: 10.1002/(SICI)1096-8628(19961002)65:1<27::AID-AJMG4>3.0.CO;2-V

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  10 in total

1.  Overexpression of a human potassium channel suppresses cardiac hyperexcitability in rabbit ventricular myocytes.

Authors:  H B Nuss; E Marbán; D C Johns
Journal:  J Clin Invest       Date:  1999-03       Impact factor: 14.808

2.  Functional characterization of the C-terminus of the human ether-à-go-go-related gene K(+) channel (HERG).

Authors:  E Aydar; C Palmer
Journal:  J Physiol       Date:  2001-07-01       Impact factor: 5.182

3.  Variable expression of long QT syndrome among gene carriers from families with five different HERG mutations.

Authors:  Jesaia Benhorin; Arthur J Moss; Matthew Bak; Wojciech Zareba; Elizabeth S Kaufman; Batsheva Kerem; Jeffrey A Towbin; Silvia Priori; Robert S Kass; Bernard Attali; Arthur M Brown; Eckhard Ficker
Journal:  Ann Noninvasive Electrocardiol       Date:  2002-01       Impact factor: 1.468

4.  Clinical, genetic, and electrophysiologic characteristics of a new PAS-domain HERG mutation (M124R) causing Long QT syndrome.

Authors:  Liat Shushi; Batsheva Kerem; Maya Goldmit; Asher Peretz; Bernard Attali; Aron Medina; Jeffrey A Towbin; Junko Kurokawa; Robert S Kass; Jesaia Benhorin
Journal:  Ann Noninvasive Electrocardiol       Date:  2005-07       Impact factor: 1.468

5.  Fluid flow modulates electrical activity in cardiac hERG potassium channels.

Authors:  Samrat Roy; M K Mathew
Journal:  J Biol Chem       Date:  2018-01-05       Impact factor: 5.157

6.  N-linked glycosylation sites determine HERG channel surface membrane expression.

Authors:  K Petrecca; R Atanasiu; A Akhavan; A Shrier
Journal:  J Physiol       Date:  1999-02-15       Impact factor: 5.182

7.  Quantitative prediction of the arrhythmogenic effects of de novo hERG mutations in computational models of human ventricular tissues.

Authors:  Alan P Benson; Moza Al-Owais; Arun V Holden
Journal:  Eur Biophys J       Date:  2011-01-14       Impact factor: 1.733

Review 8.  Molecular pathogenesis of long QT syndrome type 2.

Authors:  Jennifer L Smith; Corey L Anderson; Don E Burgess; Claude S Elayi; Craig T January; Brian P Delisle
Journal:  J Arrhythm       Date:  2016-01-22

Review 9.  Mutation-Specific Differences in Kv7.1 (KCNQ1) and Kv11.1 (KCNH2) Channel Dysfunction and Long QT Syndrome Phenotypes.

Authors:  Peter M Kekenes-Huskey; Don E Burgess; Bin Sun; Daniel C Bartos; Ezekiel R Rozmus; Corey L Anderson; Craig T January; Lee L Eckhardt; Brian P Delisle
Journal:  Int J Mol Sci       Date:  2022-07-02       Impact factor: 6.208

10.  Estimating the Posttest Probability of Long QT Syndrome Diagnosis for Rare KCNH2 Variants.

Authors:  Krystian Kozek; Yuko Wada; Luca Sala; Isabelle Denjoy; Christian Egly; Matthew J O'Neill; Takeshi Aiba; Wataru Shimizu; Naomasa Makita; Taisuke Ishikawa; Lia Crotti; Carla Spazzolini; Maria-Christina Kotta; Federica Dagradi; Silvia Castelletti; Matteo Pedrazzini; Massimiliano Gnecchi; Antoine Leenhardt; Joe-Elie Salem; Seiko Ohno; Yi Zuo; Andrew M Glazer; Jonathan D Mosley; Dan M Roden; Bjorn C Knollmann; Jeffrey D Blume; Fabrice Extramiana; Peter J Schwartz; Minoru Horie; Brett M Kroncke
Journal:  Circ Genom Precis Med       Date:  2021-07-26
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.